Justin Chakma

Insider Reports History

Location
San Diego, CA
Signature
/s/ Kathleen Scott, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Justin Chakma:

Company Role Class Num Shares Value Price $ Report Date Ownership
ARS Pharmaceuticals, Inc. Chief Business Officer Common Stock 0 $0 $8.86 12 Nov 2025 Direct
ARS Pharmaceuticals, Inc. Chief Business Officer Stock option (right to buy) 240,000 02 Jan 2026 Direct

Insider Reports Filed by Justin Chakma

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SPRY ARS Pharmaceuticals, Inc. 02 Jan 2026 1 $0 4 Chief Business Officer 05 Jan 2026, 16:22
SPRY ARS Pharmaceuticals, Inc. 12 Nov 2025 4 -$1,450,947 4 Chief Business Officer 14 Nov 2025, 18:42
SPRY ARS Pharmaceuticals, Inc. 02 Jan 2025 1 $0 4 Chief Business Officer 03 Jan 2025, 16:30
SPRY ARS Pharmaceuticals, Inc. 12 Dec 2024 6 -$1,630,262 4 Chief Business Officer 13 Dec 2024, 19:53
SPRY ARS Pharmaceuticals, Inc. 10 Dec 2024 3 -$615,625 4 Chief Business Officer 12 Dec 2024, 17:41
SPRY ARS Pharmaceuticals, Inc. 04 Dec 2024 9 -$1,919,702 4 Chief Business Officer 06 Dec 2024, 19:15
SPRY ARS Pharmaceuticals, Inc. 02 Dec 2024 8 -$1,133,019 4 Chief Business Officer 04 Dec 2024, 21:45
SPRY ARS Pharmaceuticals, Inc. 25 Nov 2024 3 -$1,411,742 4 Chief Business Officer 27 Nov 2024, 16:11
SPRY ARS Pharmaceuticals, Inc. 02 Jan 2024 1 $0 4 Chief Business Officer 04 Jan 2024, 16:41
SPRY ARS Pharmaceuticals, Inc. 03 Jan 2023 1 $0 4 Chief Business Officer 05 Jan 2023, 16:00
SPRY ARS Pharmaceuticals, Inc. 08 Nov 2022 5 $0 4 Chief Business Officer 10 Nov 2022, 17:00
SPRY ARS Pharmaceuticals, Inc. 08 Nov 2022 0 $0 3 Chief Business Officer 10 Nov 2022, 16:00